[go: up one dir, main page]

DE60135760D1 - Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess - Google Patents

Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess

Info

Publication number
DE60135760D1
DE60135760D1 DE60135760T DE60135760T DE60135760D1 DE 60135760 D1 DE60135760 D1 DE 60135760D1 DE 60135760 T DE60135760 T DE 60135760T DE 60135760 T DE60135760 T DE 60135760T DE 60135760 D1 DE60135760 D1 DE 60135760D1
Authority
DE
Germany
Prior art keywords
evening primrose
primrose seed
aforementioned
defatted
absorption inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60135760T
Other languages
English (en)
Inventor
Yotaro Konishi
Michio Aitani
Hiroshi Yamaguchi
Tsutomu Arimura
Tadashi Okada
Hiromichi Murai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oryza Oil and Fat Chemical Co Ltd
Original Assignee
Oryza Oil and Fat Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oryza Oil and Fat Chemical Co Ltd filed Critical Oryza Oil and Fat Chemical Co Ltd
Application granted granted Critical
Publication of DE60135760D1 publication Critical patent/DE60135760D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
DE60135760T 2000-08-01 2001-07-26 Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess Expired - Lifetime DE60135760D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000232930 2000-08-01
PCT/JP2001/006436 WO2002009734A1 (en) 2000-08-01 2001-07-26 Sugar absorption inhibitors and process for producing the same

Publications (1)

Publication Number Publication Date
DE60135760D1 true DE60135760D1 (de) 2008-10-23

Family

ID=18725531

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60135760T Expired - Lifetime DE60135760D1 (de) 2000-08-01 2001-07-26 Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess

Country Status (8)

Country Link
US (2) US6932990B2 (de)
EP (1) EP1312374B1 (de)
JP (1) JP4873824B2 (de)
CN (1) CN1268351C (de)
AT (1) ATE407689T1 (de)
AU (1) AU2001276682A1 (de)
DE (1) DE60135760D1 (de)
WO (1) WO2002009734A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US7713546B1 (en) 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
US7666459B2 (en) 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
KR20030075947A (ko) * 2002-03-19 2003-09-26 제네티카 주식회사 신 혈관형성을 억제하는 물질
EP1545554A4 (de) * 2002-07-24 2006-06-14 Univ Ohio Verfahren und zusammensetzungen zur behandlung von diabetes mellitus
JP4541662B2 (ja) * 2003-05-29 2010-09-08 オリザ油化株式会社 抗ピロリ菌組成物
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
US20090274777A1 (en) 2003-10-06 2009-11-05 Hiroshi Shimoda Dietetic composition
JP2006335758A (ja) * 2003-10-06 2006-12-14 Oriza Yuka Kk ダイエット用組成物
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
EP1557094A1 (de) * 2004-01-26 2005-07-27 Wageningen Centre for Food Sciences Verbesserte halb-feste Lebensmittel und Methode zu ihrer Herstellung basierend auf der Inhibierung des von Amylasen induzierten Stärke Abbaus
US20050251265A1 (en) * 2004-05-07 2005-11-10 Calandruccio James H Trapezium implant for thumb and method
US20050249837A1 (en) * 2004-05-10 2005-11-10 The Procter & Gamble Company Processes for preparing plant matter extracts and pet food compositions
US20090252834A1 (en) * 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
AU2005249147B2 (en) 2004-06-04 2011-03-24 Poly Gain Pte Ltd Natural sweetener
JP5020462B2 (ja) * 2004-06-16 2012-09-05 クラシエフーズ株式会社 α−グルコシダーゼ阻害剤及びそれを用いた食品
JP2006016330A (ja) * 2004-06-30 2006-01-19 Suntory Ltd 脂肪燃焼促進剤
US20060051435A1 (en) * 2004-08-19 2006-03-09 Udell Ronald G Nutritional supplement for body fat reduction
JP2006056850A (ja) * 2004-08-23 2006-03-02 Suntory Ltd リパーゼ阻害剤
ATE464564T1 (de) 2004-08-30 2010-04-15 Takeda Pharmaceutical Screening-verfahren
JP2006104181A (ja) * 2004-09-13 2006-04-20 Takahiro Tsujita ブナ科植物由来の糖質分解酵素阻害物質、及びその用途
CN100566723C (zh) * 2004-09-13 2009-12-09 辻田隆广 衍生自壳斗植物的糖酶抑制剂及其应用
EP2261323A1 (de) 2005-05-31 2010-12-15 The Iams Company Probiotische Katzen-Laktobazillen
EP1885383B1 (de) 2005-05-31 2016-09-21 IAMS Europe B.V. Katzen probiotisches bifidobacterium
CA2608865C (en) 2005-06-03 2015-08-25 Horizon Science Pty Ltd Molasses extract having body mass redistribution properties
WO2007019526A2 (en) * 2005-08-05 2007-02-15 Naturegen, Inc. Compositions and methods for controlling glucose and lipid uptake from foods
KR100829083B1 (ko) 2006-07-28 2008-05-16 재단법인 제주하이테크산업진흥원 생리활성을 갖는 애기달맞이 추출물
CN101553582A (zh) * 2006-09-19 2009-10-07 视界科技有限公司 从甘蔗中获得的提取物及其生产方法
MX2009008165A (es) * 2007-02-01 2009-08-12 Iams Company Metodo para disminuir la inflamacion y el esfuerzo oxidante en mamiferos.
EP2124966B1 (de) * 2007-02-01 2015-09-09 IAMS Europe B.V. Verfahren zur verringerung von entzündung und oxidativem stress bei einem säugetier mit glucose-antimetaboliten, avocado oder avocado-extrakten
EP2303252A1 (de) 2008-05-15 2011-04-06 Alois Jungbauer Verbindungen zur behandlung des metabolischen syndroms und von insulin-resistenz
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US20110236340A1 (en) * 2008-08-22 2011-09-29 Relypsa, Inc. Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia
KR101672026B1 (ko) * 2008-10-08 2016-11-02 가부시키가이샤 포카코포레이션 항-조류 인플루엔자 바이러스제, 및 항-조류 인플루엔자 바이러스제를 함유하는 제품
JP2010184909A (ja) * 2009-02-13 2010-08-26 Rheology Kino Shokuhin Kenkyusho:Kk 機能性組成物およびこの組成物を含有する医薬又は健康食品
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CN102018766B (zh) * 2009-09-16 2013-03-06 博仲盛景医药技术（北京）有限公司 一种植物提取物、其提取方法和用途及含有这种提取物的组合物
US9572852B2 (en) 2011-02-08 2017-02-21 The Product Makers (Australia) Pty Ltd Sugar extracts
RU2451506C1 (ru) * 2011-06-02 2012-05-27 Сергей Юрьевич Лешков Комбинация для лечения сахарного диабета и его осложнений
EP2890467B1 (de) 2012-08-28 2019-09-25 The Product Makers (Australia) Pty Ltd Extraktionsverfahren
JP2014198684A (ja) * 2013-03-29 2014-10-23 サンスター株式会社 血糖代謝改善剤
AU2014306366B9 (en) 2013-08-16 2020-03-26 Poly Gain Pte Ltd Sugar cane derived extracts and methods of treatment
JP6998108B2 (ja) 2016-03-07 2022-01-18 株式会社ダイセル ウロリチン類を含有するα－グルコシダーゼ活性阻害剤、およびウロリチン類を含有する血糖値上昇抑制剤
CN111526735A (zh) * 2017-12-27 2020-08-11 三得利控股株式会社 肠道屏障功能改善用组合物
WO2022085602A1 (ja) * 2020-10-20 2022-04-28 サントリーホールディングス株式会社 Ｔｇｒ５活性化用組成物
JP2023035438A (ja) * 2021-09-01 2023-03-13 ビーエイチエヌ株式会社 血糖値上昇抑制剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3018013B2 (ja) * 1989-10-19 2000-03-13 三井農林株式会社 α―アミラーゼ活性阻害剤
WO1997023210A1 (en) * 1995-12-26 1997-07-03 Suntory Limited Antiobestic agent containing procyanidin as the active ingredient
JPH09176019A (ja) * 1995-12-26 1997-07-08 Suntory Ltd 糖質分解消化酵素阻害剤並びにこれを配合した医薬品および飲食品
WO2000018416A1 (en) * 1998-09-30 2000-04-06 Industrial Research Limited Antioxidant compositions and process for their preparation

Also Published As

Publication number Publication date
ATE407689T1 (de) 2008-09-15
AU2001276682A1 (en) 2002-02-13
JP4873824B2 (ja) 2012-02-08
US20030161903A1 (en) 2003-08-28
WO2002009734A1 (en) 2002-02-07
US20060024396A1 (en) 2006-02-02
EP1312374B1 (de) 2008-09-10
WO2002009734A8 (en) 2002-02-28
CN1268351C (zh) 2006-08-09
EP1312374A1 (de) 2003-05-21
US6932990B2 (en) 2005-08-23
CN1468106A (zh) 2004-01-14
EP1312374A4 (de) 2004-04-21

Similar Documents

Publication Publication Date Title
DE60135760D1 (de) Nachtkerzensamenextrakte als inhibitoren der zuckerabsorption und deren herstellungsprozess
Mehenni et al. Hepatoprotective and antidiabetic effects of Pistacia lentiscus leaf and fruit extracts
Thuong et al. Antioxidant activities of coumarins from Korean medicinal plants and their structure–activity relationships
Oniszczuk et al. Extraction methods for the determination of phenolic compounds from Equisetum arvense L. herb
Rostagno et al. Pressurized liquid extraction of isoflavones from soybeans
Juan-Badaturuge et al. Antioxidant compounds from a South Asian beverage and medicinal plant, Cassia auriculata
Abd Ghafar et al. Antioxidant, α-glucosidase, and nitric oxide inhibitory activities of Phyllanthus acidus and LC–MS/MS profile of the active extract
Kordbacheh et al. Anti-quorum sensing activity of Pistacia atlantica against Pseudomonas aeruginosa PAO1 and identification of its bioactive compounds
Ikewuchi et al. Bioactive phytochemicals in an aqueous extract of the leaves of Talinum triangulare
Pacifico et al. Neuroprotective potential of Laurus nobilis antioxidant polyphenol-enriched leaf extracts
Tung et al. Antioxidative phytochemicals from Rhododendron oldhamii Maxim. leaf extracts reduce serum uric acid levels in potassium oxonate-induced hyperuricemic mice
CA2633571A1 (en) Recovery of residual plant components after distillation of essential oils
Pires et al. Qualitative and quantitative analysis of the phenolic content of Connarus var. angustifolius, Cecropia obtusa, Cecropia palmata and Mansoa alliacea based on HPLC-DAD and UHPLC-ESI-MS/MS
Díaz-de-Cerio et al. Establishment of pressurized-liquid extraction by response surface methodology approach coupled to HPLC-DAD-TOF-MS for the determination of phenolic compounds of myrtle leaves
Salem et al. In vitro anti-uveal melanoma activity of phenolic compounds from the Egyptian medicinal plant Acacia nilotica
WO2007080514A3 (en) A method for the extraction of lipid fractions from krill
Golder et al. Comparative pharmacologic profiles of leaves and hypocotyls of a mangrove plant: Bruguiera gymnorrhiza
Santos et al. In vitro anthelmintic and cytotoxicity activities the Digitaria insularis (Poaceae)
Barros et al. Antioxidant and hepatoprotective activities of Libidibia ferrea bark and fruit extracts
KR20010052636A (ko) 하이페리쿰 퍼포라툼의 추출물 및 그를 함유한 제제
Batubara et al. The best extraction technique for kaempferol and quercetin isolation from guava leaves (Psidium guajava)
Tatke et al. Isolation of quercetin-3-O-β-D-glucoside from Azadirachta indica
Raduan et al. Antioxidant capabilities of Litsea garciae bark extracts and their relation to the phytochemical compositions
MXPA05010416A (es) Combinacion de substancias activas de aceites minerales que contienen acidos grasos (3 con extractos vegetales que contengan polifenoles y su uso.
Mandal et al. Quality Standards and Anti-oxidant Activity of Siddha Formulation Cuvacakutori Chooranam

Legal Events

Date Code Title Description
8364 No opposition during term of opposition